The osteogenic transcription factor Runx2 controls genes involved in sterol/steroid metabolism, including Cyp11a1 in osteoblasts

Molecular Endocrinology

Volumn 23, Issue 6, 2009, Pages 849-861

  Teplyuk, Nadiya M ^a   Zhang, Ying ^a   Lou, Yang ^a   Hawse, John R ^b   Hassan, Mohammad Q ^a   Teplyuk, Viktor I ^a   Pratap, Jitesh ^a   Galindo, Mario ^c   Stein, Janet L ^a   Stein, Gary S ^a   Lian, Jane B ^a   Van Wijnen, Andre J ^a,d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF CHILE   (Chile)

^d Department of Cell Biology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYP39A1; CYTOCHROME; MITOCHONDRIAL ENZYME; SHORT HAIRPIN RNA; STEROL 14ALPHA DEMETHYLASE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER CELL; CELL NUCLEUS; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CHROMATIN IMMUNOPRECIPITATION; CYTOPLASM; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STEROID METABOLISM; STEROIDOGENESIS; STEROL METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; ISOENZYMES; MICE; MITOCHONDRIA; MOLECULAR WEIGHT; OSTEOBLASTS; OSTEOGENESIS; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, SMALL INTERFERING; STEROLS; TRANSCRIPTIONAL ACTIVATION;

MURINAE;

EID: 66449114694     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0270     Document Type: Article

References (79)

1. Vanderschueren D, Gaytant J, Boonen S, Venken K 2008 Androgens and bone. Curr Opin Endocrinol Diabetes Obes 15:250-254
2. St-Arnaud R 2008 The direct role of vitamin D on bone homeostasis. Arch Biochem Biophys 473:225-230
3. Canalis E, Mazziotti G, Giustina A, Bilezikian JP 2007 Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328 (Pubitemid 47389469)
4. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP 2004 Genetics and biology of vitamin D receptor polymorphisms. Gene 338:143-156 (Pubitemid 39094759)
5. Syed F, Khosla S 2005 Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688-696 (Pubitemid 40214350)
6. Centrella M, Christakos S, McCarthy TL 2004 Skeletal hormones and the C/EBP and Runx transcription factors: interactions that integrate and redefine gene expression. Gene 342:13-24 (Pubitemid 39457172)
7. van Driel M, Pols HA, van Leeuwen JP 2004 Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des 10:2535-2555 (Pubitemid 39004077)
8. Yanase T, Suzuki S, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H 2003 Aromatase in bone: roles of vitamin D3 and androgens. J Steroid Biochem Mol Biol 86:393-397 (Pubitemid 37412577)
9. Boyan BD, Dean DD, Sylvia VL, Schwartz Z 2003 Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms. Connect Tissue Res 44(Suppl 1):130-135 (Pubitemid 36395434)
10. Riggs BL, Khosla S, Melton 3rd LJ 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302 (Pubitemid 34651948)
11. Kato S, Takeyama K, Kitanaka S, Murayama A, Sekine K, Yoshizawa T 1999 In vivo function of VDR in gene expression-VDR knock-out mice. J Steroid Biochem Mol Biol 69:247-251
12. Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, Aihara K, Yamamoto Y, Nakamichi Y, Metzger D, Chambon P, Nakamura K, Kawaguchi H, Kato S 2003 Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 100:9416-9421 (Pubitemid 37033943)
13. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061 (Pubitemid 24317698)
14. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698
15. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER 1997 Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91-95 (Pubitemid 27284394)
16. Migliaccio S, Brama M, Fornari R, Greco EA, Spera G, Malavolta N 2007 Glucocorticoid-induced osteoporosis: an osteoblastic disease. Aging Clin Exp Res 19:5-10
17. McClung MR 2005 The relationship between bone mineral density and fracture risk. Curr Osteoporos Rep 3:57-63
18. Sørensen MG, Henriksen K, Schaller S, Karsdal MA 2007 Biochemical markers in preclinical models of osteoporosis. Biomarkers 12:266-286 (Pubitemid 46681030)
19. Rosen CJ 2003 The cellular and clinical parameters of anabolic therapy for osteoporosis. Crit Rev Eukaryot Gene Expr 13:25-38 (Pubitemid 36834694)
20. Windahl SH, Andersson G, Gustafsson JA 2002 Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab 13:195-200 (Pubitemid 36733979)
21. Windahl SH, Lagerquist MK, Andersson N, Jochems C, Kallkopf A, Håkansson C, Inzunza J, Gustafsson JA, van der Saag PT, Carlsten H, Pettersson K, Ohlsson C 2007 Identification of target cells for the genomic effects of estrogens in bone. Endocrinology 148:5688-5695 (Pubitemid 350146165)
22. McCarthy TL, Ji C, Shu H, Casinghino S, Crothers K, Rotwein P, Centrella M 1997 17β-Estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures. J Biol Chem 272:18132-18139 (Pubitemid 27306398)
23. Ray A, Prefontaine KE, Ray P 1994 Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269:12940-12946 (Pubitemid 24202095)
24. Stein B, Yang MX 1995 Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol 15:4971-4979
25. Suda T, Nakamura I, Jimi E, Takahashi N 1997 Regulation of osteoclast function. J Bone Miner Res 12:869-879 (Pubitemid 27224995)
26. Jilka RL, Weinstein RS, Parfitt AM, Manolagas SC 2007 Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res 22:1492-1501
27. McCarthy TL, Clough ME, Gundberg CM, Centrella M 2008 Expression of an estrogen receptor agonist in differentiating osteoblast cultures. Proc Natl Acad Sci USA 105:7022-7027
28. McCarthy TL, Hochberg RB, Labaree DC, Centrella M 2007 3-Ketosteroid reductase activity and expression by fetal rat osteoblasts. J Biol Chem 282:34003-34012 (Pubitemid 350159449)
29. Centrella M, McCarthy TL, Chang WZ, Labaree DC, Hochberg RB 2004 Estren (4-estren-3α,17β-diol) is a prohormone that regulates both androgenic and estrogenic transcriptional effects through the androgen receptor. Mol Endocrinol 18:1120-1130 (Pubitemid 38591279)
30. Sierra J, Villagra A, Paredes R, Cruzat F, Gutierrez S, Javed A, Arriagada G, Olate J, Imschenetzky M, van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M 2003 Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol 23:3339-3351 (Pubitemid 36459245)
31. McCarthy TL, Chang WZ, Liu Y, Centrella M 2003 Runx2 integrates estrogen activity in osteoblasts. J Biol Chem 278:43121-43129 (Pubitemid 37345930)
32. Shen Q, Christakos S 2005 The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem 280:40589-40598 (Pubitemid 41780549)
33. Kitazawa S, Kajimoto K, Kondo T, Kitazawa R 2003 Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J Cell Biochem 89:771-777 (Pubitemid 36759137)
34. Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, Hsieh JC, Kaczmarska M, Haussler CA, Haussler MR 2007 Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res 22(Suppl 2):V2-V10
35. van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y, Liu P, Neil JC, Ohki M, Speck N 2004 Nomenclature for Runt-related (RUNX) proteins. Oncogene 23:4209-4210 (Pubitemid 38758585)
36. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS 1995 The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 34:13125-13132
37. Banerjee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, Lian JB 1997 Runt homology domain proteins in osteoblast differentiation: AML-3/CBFA1 is a major component of a bone specific complex. J Cell Biochem 66:1-8 (Pubitemid 27284091)
38. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754 (Pubitemid 27516177)
39. 2Vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp Cell Res 274:323-333
40. Viereck V, Siggelkow H, Tauber S, Raddatz D, Schutze N, Hüfner M 2002 Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J Cell Biochem 86:348-356 (Pubitemid 34743391)
41. Phillips JE, Gersbach CA, Wojtowicz AM, García AJ 2006 Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J Cell Sci 119:581-591
42. Kawate H, Wu Y, Ohnaka K, Takayanagi R 2007 Mutual transactivational repression of Runx2 and the androgen receptor by an impairment of their normal compartmentalization. J Steroid Biochem Mol Biol 105:46-56 (Pubitemid 47211955)
43. Mikami Y, Takahashi T, Kato S, Takagi M 2008 Dexamethasone promotes DMP1 mRNA expression by inhibiting negative regulation of Runx2 in multipotential mesenchymal progenitor, ROB-C26. Cell Biol Int 32:239-246
44. +/- mice. Bone 41:25-32
45. Young DW, Hassan MQ, Pratap J, Galindo M, Zaidi SK, Lee SH, Yang X, Xie R, Javed A, Underwood JM, Furcinitti P, Imbalzano AN, Penman S, Nickerson JA, Montecino MA, Lian JB, Stein JL, van Wijnen AJ, Stein GS 2007 Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 445:442-446 (Pubitemid 46160913)
46. Young DW, Hassan MQ, Yang XQ, Galindo M, Javed A, Zaidi SK, Furcinitti P, Lapointe D, Montecino M, Lian JB, Stein JL, van Wijnen AJ, Stein GS 2007 Mitotic retention of gene expression patterns by the cell fate determining transcription factor Runx2. Proc Natl Acad Sci USA 104:3189-3194 (Pubitemid 46364135)
47. Pratap J, Galindo M, Zaidi SK, Vradii D, Bhat BM, Robinson JA, Choi JY, Komori T, Stein JL, Lian JB, Stein GS, van Wijnen AJ 2003 Cell growth regulatory role of Runx2 during proliferative expansion of pre-osteoblasts. Cancer Res 63:5357-5362 (Pubitemid 37139851)
48. Galindo M, Pratap J, Young DW, Hovhannisyan H, Im HJ, Choi JY, Lian JB, Stein JL, Stein GS, van Wijnen AJ 2005 The bone-specific expression of RUNX2 oscillates during the cell cycle to support a G1 related anti-proliferative function in osteoblasts. J Biol Chem 280:20274-20285 (Pubitemid 40776725)
49. Zaidi SK, Pande S, Pratap J, Gaur T, Grigoriu S, Ali SA, Stein JL, Lian JB, van Wijnen AJ, Stein GS 2007 Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc Natl Acad Sci USA 104:19861-19866
50. Kilbey A, Blyth K, Wotton S, Terry A, Jenkins A, Bell M, Hanlon L, Cameron ER, Neil JC 2007 Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Res 67:11263-11271 (Pubitemid 350248552)
51. Teplyuk NM, Galindo M, Teplyuk VI, Pratap J, Young DW, Lapointe D, Javed A, Stein JL, Lian JB, Stein GS, van Wijnen AJ 2008 Runx2 regulates G-protein coupled signaling pathways to control growth of osteoblast progenitors. J Biol Chem 283:27585-27597
52. Blyth K, Vaillant F, Hanlon L, Mackay N, Bell M, Jenkins A, Neil JC, Cameron ER 2006 Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. Cancer Res 66:2195-2201 (Pubitemid 43294930)
53. Blyth K, Cameron ER, Neil JC 2005 The runx genes: gain or loss of function in cancer. Nat Rev Cancer 5:376-387 (Pubitemid 40637829)
54. Galindo M, Kahler RA, Teplyuk NM, Stein JL, Lian JB, Stein GS, Westendorf JJ, van Wijnen AJ 2007 Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts. J Mol Histol 38:501-506 (Pubitemid 350056782)
55. Wotton S, Terry A, Kilbey A, Jenkins A, Herzyk P, Cameron E, Neil JC 2008 Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival. Oncogene 27:5856-5866
56. Otto F, Lübbert M, Stock M 2003 Upstream and downstream targets of RUNX proteins. J Cell Biochem 89:9-18 (Pubitemid 36459094)
57. Stock M, Schfer H, Fliegauf M, Otto F 2004 Identification of novel genes of the bone-specific transcription factor Runx2. J Bone Miner Res 19:959-972 (Pubitemid 41103453)
58. Gaikwad JS, Cavender A, D'Souza RN 2001 Identification of tooth-specific downstream targets of Runx2. Gene 279:91-97 (Pubitemid 33145186)
59. Bae JS, Gutierrez S, Narla R, Pratap J, Devados R, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Javed A 2007 Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation. J Cell Biochem 100:434-449 (Pubitemid 46146092)
60. Storbeck KH, Swart P, Swart AC 2007 Cytochrome P450 side-chain cleavage: insights gained from homology modeling. Mol Cell Endocrinol 265-266:65-70 (Pubitemid 46273952)
61. Pikuleva IA 2006 Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 112:761-773 (Pubitemid 44573496)
62. Jo M, Curry Jr TE 2006 Luteinizing hormone-induced RUNX1 regulates the expression of genes in granulosa cells of rat periovulatory follicles. Mol Endocrinol 20:2156-2172 (Pubitemid 44286711)
63. Shimada M, Hernandez-Gonzalez I, Gonzalez-Robayna I, Richards JS 2006 Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: key roles for prostaglandin synthase 2 and progesterone receptor. Mol Endocrinol 20:1352-1365 (Pubitemid 43801236)
64. Miller WL 1995 Mitochondrial specificity of the early steps in steroidogenesis. J Steroid Biochem Mol Biol 55:607-616 (Pubitemid 26019345)
65. Lambeth JD, Stevens VL 1984 Cytochrome P-450scc: enzymology, and the regulation of intramitochondrial cholesterol delivery to the enzyme. Endocr Res 10:283-309 (Pubitemid 15018387)
66. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW 2004 Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1-18 (Pubitemid 38183957)
67. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi K, van Wijnen A, Lian JB, Stein GS, Stein JL, Montecino M 2004 Bone-specific transcription factor Runx2 interacts with the 1α,25-dihydroxyvitamin D3 receptor to upregulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24:8847-8861 (Pubitemid 39313891)
68. Lambertini E, Penolazzi L, Tavanti E, Schincaglia GP, Zennaro M, Gambari R, Piva R 2007 Human estrogen receptor α gene is a target of Runx2 transcription factor in osteoblasts. Exp Cell Res 313:1548-1560 (Pubitemid 46589433)
69. Viccica G, Vignali E, Marcocci C 2007 Role of the cholesterol biosynthetic pathway in osteoblastic differentiation. J Endocrinol Invest 30:8-12
70. Jeong JH, Jin JS, Kim HN, Kang SM, Liu JC, Lengner CJ, Otto F, Mundlos S, Stein JL, van Wijnen AJ, Lian JB, Stein GS, Choi JY 2008 Expression of Runx2 transcription factor in non-skeletal tissues, sperm and brain. J Cell Physiol 217:511-517
71. Hu MC, Hsu NC, El Hadj NB, Pai CI, Chu HP, Wang CK, Chung BC 2002 Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1. Mol Endocrinol 16:1943-1950 (Pubitemid 34828100)
72. Tuckey RC, Li W, Zjawiony JK, Zmijewski MA, Nguyen MN, Sweatman T, Miller D, Slominski A 2008 Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J 275:2585-2596
73. Zbytek B, Janjetovic Z, Tuckey RC, Zmijewski MA, Sweatman TW, Jones E, Nguyen MN, Slominski AT 2008 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol 128:2271-2280
74. Slominski A, Semak I, Wortsman J, Zjawiony J, Li W, Zbytek B, Tuckey RC 2006 An alternative pathway of vitamin D metabolism: cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J 273:2891-2901 (Pubitemid 43910044)
75. Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, Bodine PV, Komm BS 2001 Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 80:424-440
76. Black SM, Szklarz GD, Harikrishna JA, Lin D, Wolf CR, Miller WL 1993 Regulation of proteins in the cholesterol side-chain cleavage system in JEG-3 and Y-1 cells. Endocrinology 132:539-545 (Pubitemid 23056105)
77. Hovhannisyan H, Cho B, Mitra P, Montecino M, Stein GS, Van Wijnen AJ, Stein JL 2003 Maintenance of open chromatin and selective genomic occupancy at the cell-cycle-regulated histone H4 promoter during differentiation of HL-60 promyelocytic leukemia cells. Mol Cell Biol 23:1460-1469 (Pubitemid 36177053)
78. Hassan MQ, Javed A, Morasso MI, Karlin J, Montecino M, van Wijnen AJ, Stein GS, Stein JL, Lian JB 2004 Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol 24:9248-9261
79. Zhang Y, Hassan MQ, Li ZY, Stein JL, Lian JB, van Wijnen AJ, Stein GS 2008 Intricate gene regulatory networks of helix-loop-helix (HLH) proteins support regulation of bone-tissue related genes during osteoblast differentiation. J Cell Biochem 105:487-496